Constanze Jonak

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 580 citations

Medicine, Hematology, Oncology +12

The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients

Julia Scarisbrick, Pietro Quaglino, H. Miles Prince et al. · British Journal of Dermatology · 2018 · 236 citations · Full text

Medicine, Oncology, Pathology +16

Persistence of mature dendritic cells, T _H 2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade

Christine Bangert, Katharina Rindler, Thomas Krausgruber et al. · Science Immunology · 2021 · 182 citations

Medicine, Dermatology, Immunology +17

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

Pietro Quaglino, Milena Maule, H. Miles Prince et al. · Annals of Oncology · 2017 · 136 citations · Full text

Medicine, Dermatology, Oncology +12

Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( <scp>PROCLIPI</scp> ) study

Kevin Molloy, Constanze Jonak, Feng Jung Sherida H. Woei-A-Jin et al. · British Journal of Dermatology · 2019 · 110 citations · Full text

Medicine, Dermatology, Oncology +15